China Health Group Inc. (8225.HK)
HKD 0.14
(1.41%)
HKD 0.14
(1.41%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -57.97 Million CNY | -270.27% |
| 2022 | -15.65 Million CNY | -136.65% |
| 2021 | 42.73 Million CNY | -23.26% |
| 2020 | 55.66 Million CNY | 64.21% |
| 2019 | 33.89 Million CNY | 17.8% |
| 2018 | 28.73 Million CNY | -17.77% |
| 2017 | 34.98 Million CNY | 793.39% |
| 2016 | 3.9 Million CNY | 115.93% |
| 2015 | 1.81 Million CNY | 124.2% |
| 2014 | -7.49 Million CNY | 69.14% |
| 2013 | -24.29 Million CNY | -54080.0% |
| 2012 | 9.71 Million CNY | 100.14% |
| 2011 | -142.24 Million CNY | -25.75% |
| 2010 | -48.52 Million CNY | -269.7% |
| 2009 | 15.51 Million CNY | 202.05% |
| 2008 | -15.2 Million CNY | -249.88% |
| 2007 | 10.14 Million CNY | -53.14% |
| 2006 | 21.69 Million CNY | 213.12% |
| 2005 | 7.29 Million CNY | -42.12% |
| 2004 | 11.94 Million CNY | -46.17% |
| 2003 | 22.18 Million CNY | 11.7% |
| 2002 | 19.86 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q4 | -65.12 Million CNY | -48342.96% |
| 2023 FY | - CNY | -270.27% |
| 2023 Q1 | 1.01 Million CNY | 102.89% |
| 2023 Q2 | 5.79 Million CNY | 471.4% |
| 2023 Q3 | 135 Thousand CNY | -97.67% |
| 2022 FY | - CNY | -136.65% |
| 2022 Q2 | 10.59 Million CNY | 26.07% |
| 2022 Q3 | 181 Thousand CNY | -98.29% |
| 2022 Q4 | -35.09 Million CNY | -19491.71% |
| 2022 Q1 | 8.4 Million CNY | -26.73% |
| 2021 Q4 | 11.46 Million CNY | 284.77% |
| 2021 FY | - CNY | -23.26% |
| 2021 Q1 | 15.32 Million CNY | -54.81% |
| 2021 Q2 | 12.48 Million CNY | -18.49% |
| 2021 Q3 | 2.98 Million CNY | -76.14% |
| 2020 Q4 | 33.89 Million CNY | 194.79% |
| 2020 Q3 | 11.49 Million CNY | -14.93% |
| 2020 Q2 | 13.51 Million CNY | 12.22% |
| 2020 FY | - CNY | 64.21% |
| 2020 Q1 | 12.04 Million CNY | -15.68% |
| 2019 Q4 | 14.28 Million CNY | 65031.82% |
| 2019 Q2 | 9.99 Million CNY | 19.31% |
| 2019 Q1 | 8.37 Million CNY | -15.25% |
| 2019 Q3 | -22 Thousand CNY | -100.22% |
| 2019 FY | - CNY | 17.8% |
| 2018 FY | - CNY | -17.77% |
| 2018 Q4 | 9.88 Million CNY | 3215.44% |
| 2018 Q3 | 298 Thousand CNY | -97.19% |
| 2018 Q2 | 10.58 Million CNY | 51.96% |
| 2018 Q1 | 6.96 Million CNY | -68.03% |
| 2017 FY | - CNY | 793.39% |
| 2017 Q3 | 7.19 Million CNY | 188.99% |
| 2017 Q4 | 21.79 Million CNY | 203.0% |
| 2017 Q2 | 2.48 Million CNY | -0.32% |
| 2017 Q1 | 2.49 Million CNY | 1158.05% |
| 2016 Q2 | 3.43 Million CNY | 104.53% |
| 2016 FY | - CNY | 115.93% |
| 2016 Q4 | -236 Thousand CNY | 87.37% |
| 2016 Q1 | 1.67 Million CNY | 15354.55% |
| 2016 Q3 | -1.86 Million CNY | -154.43% |
| 2015 Q4 | -11 Thousand CNY | -132.35% |
| 2015 Q1 | -821 Thousand CNY | 71.79% |
| 2015 FY | - CNY | 124.2% |
| 2015 Q2 | 1.4 Million CNY | 271.13% |
| 2015 Q3 | 34 Thousand CNY | -97.58% |
| 2014 Q1 | -1.43 Million CNY | 93.13% |
| 2014 FY | - CNY | 69.14% |
| 2014 Q3 | -3.09 Million CNY | -466.12% |
| 2014 Q2 | -546 Thousand CNY | 61.84% |
| 2014 Q4 | -2.91 Million CNY | 5.84% |
| 2013 Q3 | -1.6 Million CNY | 37.87% |
| 2013 Q1 | -598 Thousand CNY | 95.8% |
| 2013 FY | - CNY | -54080.0% |
| 2013 Q4 | -20.83 Million CNY | -1201.16% |
| 2013 Q2 | -2.57 Million CNY | -330.94% |
| 2012 Q4 | -14.24 Million CNY | -1624.42% |
| 2012 FY | - CNY | 100.14% |
| 2012 Q3 | -826 Thousand CNY | 0.0% |
| 2011 Q2 | 3.53 Million CNY | 0.0% |
| 2011 Q4 | -153.07 Million CNY | -9277.04% |
| 2011 FY | - CNY | -25.75% |
| 2011 Q3 | 1.66 Million CNY | -52.75% |
| 2010 FY | - CNY | -269.7% |
| 2010 Q1 | 1.96 Million CNY | -59.33% |
| 2010 Q2 | 3.97 Million CNY | 102.55% |
| 2010 Q3 | 2.39 Million CNY | -39.71% |
| 2010 Q4 | -59.61 Million CNY | -2588.06% |
| 2009 Q2 | -21 Thousand CNY | 0.0% |
| 2009 FY | - CNY | 202.05% |
| 2009 Q3 | 5.68 Million CNY | 27180.95% |
| 2009 Q4 | 4.82 Million CNY | -15.17% |
| 2008 FY | - CNY | -249.88% |
| 2007 FY | - CNY | -53.14% |
| 2006 FY | - CNY | 213.12% |
| 2005 FY | - CNY | -42.12% |
| 2004 FY | - CNY | -46.17% |
| 2003 FY | - CNY | 11.7% |
| 2002 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Life Healthcare Group Limited | 27.68 Million HKD | 309.394% |
| China Biotech Services Holdings Limited | -73.45 Million HKD | 21.072% |